221 related articles for article (PubMed ID: 32100871)
1. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
[TBL] [Abstract][Full Text] [Related]
2. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
[TBL] [Abstract][Full Text] [Related]
3. Discriminating miRNA Profiles between Endometrioid Well- and Poorly-Differentiated Tumours and Endometrioid and Serous Subtypes of Endometrial Cancers.
Kalinkova L; Kajo K; Karhanek M; Wachsmannova L; Suran P; Zmetakova I; Fridrichova I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842533
[TBL] [Abstract][Full Text] [Related]
4. Integrated microRNA and mRNA transcriptome sequencing reveals the potential roles of miRNAs in stage I endometrioid endometrial carcinoma.
Xiong H; Li Q; Liu S; Wang F; Xiong Z; Chen J; Chen H; Yang Y; Tan X; Luo Q; Peng J; Xiao G; Jiang Q
PLoS One; 2014; 9(10):e110163. PubMed ID: 25329664
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Chung TK; Cheung TH; Huen NY; Wong KW; Lo KW; Yim SF; Siu NS; Wong YM; Tsang PT; Pang MW; Yu MY; To KF; Mok SC; Wang VW; Li C; Cheung AY; Doran G; Birrer MJ; Smith DI; Wong YF
Int J Cancer; 2009 Mar; 124(6):1358-65. PubMed ID: 19065659
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
[TBL] [Abstract][Full Text] [Related]
9. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
10. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
[TBL] [Abstract][Full Text] [Related]
11. miR-200a, miR-200b and miR-429 are onco-miRs that target the PTEN gene in endometrioid endometrial carcinoma.
Yoneyama K; Ishibashi O; Kawase R; Kurose K; Takeshita T
Anticancer Res; 2015 Mar; 35(3):1401-10. PubMed ID: 25750291
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
Wu W; Lin Z; Zhuang Z; Liang X
Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
[TBL] [Abstract][Full Text] [Related]
13. [Expression and its clinical significance of hsa-miR-155 in serum of endometrial cancer].
Tan ZQ; Liu FX; Tang HL; Su Q
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):772-4. PubMed ID: 21176560
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
BMC Cancer; 2012 Aug; 12():369. PubMed ID: 22920721
[TBL] [Abstract][Full Text] [Related]
15. [MicroRNA expression signature profile and its clinical significance in endometrioid carcinoma].
Wang Y; Adila S; Zhang X; Dong Y; Li W; Zhou M; Li T
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):88-94. PubMed ID: 24742567
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
[TBL] [Abstract][Full Text] [Related]
17. The FOXO1-miR27 tandem regulates myometrial invasion in endometrioid endometrial adenocarcinoma.
Mozos A; Catasús L; D'Angelo E; Serrano E; Espinosa I; Ferrer I; Pons C; Prat J
Hum Pathol; 2014 May; 45(5):942-51. PubMed ID: 24746199
[TBL] [Abstract][Full Text] [Related]
18. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J
Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in endometrial cancers from black and white patients.
Maxwell GL; Shoji Y; Darcy K; Litzi T; Berchuck A; Hamilton CA; Conrads TP; Risinger JI
Am J Obstet Gynecol; 2015 Feb; 212(2):191.e1-10. PubMed ID: 25174797
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.
Wilczynski M; Danielska J; Dzieniecka M; Szymanska B; Wojciechowski M; Malinowski A
PLoS One; 2016; 11(10):e0164687. PubMed ID: 27737015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
